Prof Joe Cardaci
/content/dam/genesiscare/headshots/au-doctor-headshots/au_headshot_doctor_joe_cardaci.png
Nuclear Medicine Physician

Prof. Joe Cardaci

Prof. Joe Cardaci
Joe
Cardaci

Nuclear Medicine Physician, MBBS, FRACP, AANNMS

For patients/carers

For doctors

Nuclear Medicine Physician, MBBS, FRACP, AANNMS

Locations

Murdoch (St John of God Hospital), WA
Murdoch (St John of God Hospital)
St John of God Murdoch Hospital, 100 Murdoch Drive, Murdoch, WA, 6150, Australia
-32.067130818740424, 115.84572533810733
/au/our-centres/murdoch-oncology
WA

Languages

Fluent

  • English
  • Italian / Italiano

Biography

Clinical interests in prostate cancer and neuroendocrine tumours (NETs).

Prof Cardaci is a Nuclear Medicine Physician with a long-standing interest in theranostics. He was involved in the early development of SIRT therapy for liver cancer. He has been involved in multiple international research trials advancing the field of radionuclide therapy in advanced malignancies. Dr Cardaci's clinical interests are advanced prostate cancer, neuroendocrine tumours (NETs), and liver cancer.

Prof Cardaci also practices as a General Medicine Physician, overseeing a busy medical department at Hollywood Private Hospital, Perth. He is actively engaged in medical student and Basic Physician training, and is Adjunct Associate Professor at University of Notre Dame

quotation mark
It is a privilege to be able to work with patients with advanced malignancies, who may be dealing with uncertain outcomes. I aim to offer personalised, evidence-based care to my patients.
quotation mark

More information

Research interests
  • Novel treatments for hard-to-treat cancers and radionuclide therapies.
Professional memberships
  • FRACP
  • AANMS
Publications
  • Kesavan M, Turner JH, Meyrick D, Yeo S, Cardaci G, Lenzo NP.  Salvage radiopeptide therapy of advanced castrate-resistant prostate cancer with Lutetium-177-labelled Prostate-Specific Membrane Antigen: Efficacy and safety in routine practice. Cancer Biother Radiopharm. 2018 Sep;33(7):274-281.
  • Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B.  Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004 Nov 1;88(2):78-85.